Global Plasma Protease C1-inhibitor Treatment Market Study 2015-2025, by Segment (C1-inhibitors, Kallikrein Inhibitor (Kalbitor), Selective Bradykinin B2 Receptor Antagonist (Firazyr)), by Market (Hospital Pharmacies, Independent Pharmacies and Outlets), by Company (Shire plc, CSL Limited, Sanquin)
Snapshot
The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Drug ClassC1-inhibitors Kallikrein Inhibitor (Kalbitor) Selective Bradykinin B2 Receptor Antagonist (Firazyr)
By Dosage Type Liquid/Injectable Lyophilized Demand Coverage (Market Size & Forecast, Consumer Distribution):
The global Plasma Protease C1-inhibitor Treatment market will reach xxx Million USD in 2018 and with a CAGR if xx% between 2019-2025.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
By Drug Class
By Dosage Type
- Hospital Pharmacies
- Independent Pharmacies and Outlets
- Shire plc
- CSL Limited
- Sanquin
- Pharming Group N.V.
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
1 INDUSTRY OVERVIEW
1.1 Plasma Protease C1-inhibitor Treatment Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET BY TYPE
2.1 By Drug Class
2.1.1 C1-inhibitors
2.1.2 Kallikrein Inhibitor (Kalbitor)
2.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
2.2 By Dosage Type
2.2.1 Liquid/Injectable
2.2.2 Lyophilized
2.3 Market Size by Type
2.4 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Hospital Pharmacies
3.1.2 Independent Pharmacies and Outlets
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Shire plc (Company Profile, Sales Data etc.)
5.2 CSL Limited (Company Profile, Sales Data etc.)
5.3 Sanquin (Company Profile, Sales Data etc.)
5.4 Pharming Group N.V. (Company Profile, Sales Data etc.)
6 CONCLUSION
1.1 Plasma Protease C1-inhibitor Treatment Industry
1.1.1 Overview
1.1.2 Products of Major Companies
1.2 Market Segment
1.2.1 Industry Chain
1.2.2 Consumer Distribution
1.3 Price & Cost Overview
2 PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET BY TYPE
2.1 By Drug Class
2.1.1 C1-inhibitors
2.1.2 Kallikrein Inhibitor (Kalbitor)
2.1.3 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
2.2 By Dosage Type
2.2.1 Liquid/Injectable
2.2.2 Lyophilized
2.3 Market Size by Type
2.4 Market Forecast by Type
3 GLOBAL MARKET DEMAND
3.1 Segment Overview
3.1.1 Hospital Pharmacies
3.1.2 Independent Pharmacies and Outlets
3.2 Market Size by Demand
3.3 Market Forecast by Demand
4 MAJOR REGION MARKET
4.1 Global Market Overview
4.1.1 Market Size & Growth
4.1.2 Market Forecast
4.2 Major Region
4.2.1 Market Size & Growth
4.2.2 Market Forecast
5 MAJOR COMPANIES LIST
5.1 Shire plc (Company Profile, Sales Data etc.)
5.2 CSL Limited (Company Profile, Sales Data etc.)
5.3 Sanquin (Company Profile, Sales Data etc.)
5.4 Pharming Group N.V. (Company Profile, Sales Data etc.)
6 CONCLUSION
LIST OF TABLES
Table GLOBAL PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET 2015-2018, BY DRUG CLASS, IN USD MILLION
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in Volume
Table Shire plc Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanquin Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharming Group N.V. Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GLOBAL PLASMA PROTEASE C1-INHIBITOR TREATMENT MARKET 2015-2018, BY DRUG CLASS, IN USD MILLION
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market 2015-2018, by Dosage Type, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Drug Class, in Volume
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in USD Million
Table Global Plasma Protease C1-inhibitor Treatment Market Forecast 2019-2025, by Dosage Type, in Volume
Table Shire plc Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Shire plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CSL Limited Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of CSL Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanquin Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Sanquin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pharming Group N.V. Overview List
Table Plasma Protease C1-inhibitor Treatment Business Operation of Pharming Group N.V. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
LIST OF FIGURES
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Drug Class, in Volume
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in USD Million
Figure Global Plasma Protease C1-inhibitor Treatment Market Growth 2015-2018, by Dosage Type, in Volume
